Ipamorelin Ipamorelin is a growth hormone-releasing peptide that supports selective growth hormone release
The results of our study also strengthened the results of previous studies where peak alkaline phosphatase levels were observed in pubertal phase of skeletal maturation in comparison to post pubertal phases 33,34,35
Serum IGF-1 monitoring at 6 to 8 week intervals provides the most reliable feedback on whether the protocol is producing the intended biological effect [19]
Gobburu JV, Agers H, Jusko WJ, Ynddal L (September 1999)
Ipamorelin triggers intermittent GH spikes, promoting increased metabolic activity and fat oxidation
In a 2023 study investigating GHS-based treatments for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), hexarelin was one of two GHSs chosen for experimentation